Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005

Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005–15

Published:2017-07-15 Issue:14 Volume:74 Page:1076-1083
ISSN:1079-2082
Container-title:American Journal of Health-System Pharmacy
language:en
Short-container-title:

Author:

Fitzpatrick Margaret A.¹,Suda Katie J.²,Evans Charlesnika T.³,Hunkler Robert J.⁴,Weaver Frances⁵,Schumock Glen T.⁶

Affiliation:

1. Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Medicine, Division of Infectious Diseases, Loyola University Chicago Stritch School of Medicine, Maywood, IL

2. Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Pharmacy Systems, Outcomes and Policy, University of Illinois at Chicago College of Pharmacy, Chicago, IL

3. Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Preventive Medicine, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

4. QuintilesIMS, Professor Relations, Fountain Hills, AZ

5. Department of Veterans Affairs, Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, Hines, IL, and Department of Public Health Sciences, Loyola University Chicago Stritch School of Medicine, Maywood, IL

6. Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL

Publisher

Oxford University Press (OUP)

Subject

Health Policy,Pharmacology

Link

http://academic.oup.com/ajhp/article-pdf/74/14/1076/28336142/ajhp1076.pdf

Reference36 articles.

1. Review on antimicrobial resistance. Tackling drug-resistant infections globally: final report and recommendations (May2016). http://amr-review.org/sites/default/files/160518_Finalpaper_withcover.pdf (accessed 2016 May 25).

2. Vital signs: improving antibiotic use among hospitalized patients;Fridkin;MMWR.,2014

3. Another setting for stewardship: high rate of unnecessary antimicrobial use in a Veterans Affairs long-term care facility;Peron;J Am Geriatr Soc.,2013

4. Prevalence of inappropriate antibiotic prescriptions among US ambulatory care visits, 2010–2011;Fleming-Dutra;JAMA.,2016

5. Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?;Verweij;Clin Infect Dis.,2016

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis;Open Forum Infectious Diseases;2023-07-10

2. Outpatient antifungal prescribing patterns in the United States, 2018;Antimicrobial Stewardship & Healthcare Epidemiology;2021

3. Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium;The Journal of Infectious Diseases;2020-08-05

4. Trends in antifungal use in US hospitals, 2006–12;Journal of Antimicrobial Chemotherapy;2018-07-25

5. National trends in prescription drug expenditures and projections for 2018;American Journal of Health-System Pharmacy;2018-07-15